Mr. Shawn Steven Stansbery, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 950 W Wooster St, Bowling Green, OH 43402 Phone: 419-354-8676 |
News Archive
Scientists at The University of Texas at Austin can now map what happens neurologically when new information influences a person to change his or her mind, a finding that offers more insight into the mechanics of learning.
X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 antagonists to improve immune cell trafficking to treat cancer and rare disease, today announced results from a pilot study of X4P-001-IO in combination with Opdivo (nivolumab) in patients with clear cell renal cell carcinoma who are non-responsive to the anti-PD-1 checkpoint inhibitor Opdivo alone.
A team of French and German researchers report in the May 2008 print issue of The FASEB Journal that people with limb-girdle muscular dystrophy are missing a protein called c-FLIP, which the body uses to prevent the loss of muscle tissue.
Wednesday, April 25, marked World Malaria Day, which this year had the theme "Sustain Gains, Save Lives: Invest in Malaria."
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
› Verified 6 days ago